Finance

Lists
ALK-B:CPH
ALK-Abello A/S
DKK 237,80
+0,34%
(+0,80) 1D
20 Okt., 17:00:00 GMT+2  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for ALK-B...
Open
DKK 238,80
High
DKK 239,20
Low
DKK 236,80
Mkt. cap
48,01 mjd
Avg. vol.
227,55 k
Volume
0,00
52-wk high
DKK 271,40
52-wk low
DKK 191,80
Shares outstanding
202,57 m
No. of employees
3 k
Open
DKK 238,80
High
DKK 239,20
Low
DKK 236,80
Mkt. cap
48,01 mjd
Avg. vol.
227,55 k
Volume
0,00
52-wk high
DKK 271,40
52-wk low
DKK 191,80
Shares outstanding
202,57 m
No. of employees
3 k
News stories
From web sources and news partners
Profile
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter J. Halling
Employees2,77 k
Founded1923
Headquarters-
SectorPharmaceutical industry
Websitealk.net
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,53 mjd
1,73 mjd
1,77 mjd
1,80 mjd
Cost of goods sold
487,00 m
543,00 m
543,00 m
600,00 m
Cost of revenue
487,00 m
543,00 m
543,00 m
600,00 m
Research and development expenses
145,00 m
189,00 m
151,00 m
168,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
475,00 m
605,00 m
507,00 m
582,00 m
Operating expense
620,00 m
793,00 m
658,00 m
750,00 m
Total operating expenses
1,11 mjd
1,34 mjd
1,20 mjd
1,35 mjd
Operating income
423,00 m
397,00 m
570,00 m
445,00 m
Other non operating income
-
-
-
-
EBT including unusual items
419,00 m
393,00 m
583,00 m
452,00 m
EBT excluding unusual items
419,00 m
403,00 m
583,00 m
452,00 m
Income tax expense
105,00 m
127,00 m
146,00 m
113,00 m
Effective tax rate
25,06%
32,32%
25,04%
25,00%
Other operating expenses
-
-1,00 m
-
-
Net income
314,00 m
266,00 m
437,00 m
339,00 m
Net profit margin
20,52%
15,35%
24,68%
18,89%
Earnings per share
1,40
1,20
2,00
1,50
Interest and investment income
-
28,00 m
13,00 m
7,00 m
Interest expense
-4,00 m
-6,00 m
-
-
Net interest expenses
-4,00 m
22,00 m
13,00 m
7,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
510,00 m
400,00 m
654,00 m
531,00 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme